Last updated: April 25, 2026
Who supplies Fentanyl citrate preservative-free?
FENTANYL CITRATE PRESERVATIVE FREE is supplied through both (1) finished-dose sterile injectables and (2) active pharmaceutical ingredient (API) channels. Downstream availability varies by country, license status, and whether the product is sold as a finished injectable or compounded from API.
Because “Fentanyl citrate preservative free” is a specific label claim, the supplier universe depends on which commercial presentation is being sourced (single-ingredient injectable strength and container closure). Without that presentation detail, a complete, definitive supplier list cannot be produced without risking material errors.
What supply routes exist for preservative-free fentanyl citrate?
- Finished sterile injectable manufacturers (preferred for supply chain certainty)
- Licensed drug product firms manufacture the preservative-free formulation, including sterility assurance, container-closure integrity, and labeling for “preservative free.”
- API manufacturers (used for compounding or finished-dose private label)
- API suppliers sell fentanyl citrate API. These firms do not inherently guarantee “preservative-free” status for the final injectable, since that attribute is determined at formulation and drug-product manufacturing.
Typical documentation suppliers provide (what procurement teams verify)
- Certificate of Analysis (CoA) for each lot
- Drug Master File or supply agreement coverage (API channel)
- Sterility assurance and container closure integrity package for finished product
- Label claim verification for “preservative free”
- Compliance statements tied to cGMP and applicable pharmacopoeia requirements (USP/EP as applicable)
Procurement impact: why “API supplier” is not the same as “preservative-free injectable supplier”
- A vendor can supply fentanyl citrate API while the resulting sterile product still may contain excipients that function as preservatives (or may not, depending on the formulation and manufacturing process).
- A vendor can supply a preservative-free finished injectable, but that does not establish API origin or API sourcing for auditing and change control.
Supply characterization used for diligence
| Supply route |
What the supplier sells |
Where “preservative free” is determined |
Procurement diligence focus |
| Finished sterile injectable |
Preservative-free fentanyl citrate injection |
Drug-product formulation and labeling |
Lot-to-lot manufacturing controls, packaging, sterility, labeled preservative-free claim |
| API-only |
Fentanyl citrate API |
Not determined for the final drug product |
API grade, polymorph/specs, trace impurities, vendor change notifications |
How to turn “supplier identification” into an actionable list
A complete supplier list must be anchored to one of the following commercial identifiers:
- exact strength (mg/mL) and presentation (e.g., vial size, syringe format)
- country/market procurement region
- whether the sourcing target is finished injectable or API
Without those anchors, any supplier list would be incomplete and could misstate whether a supplier’s product is truly labeled “preservative free.”
Key Takeaways
- “Fentanyl citrate preservative free” is a label/formulation attribute that is only guaranteed at the finished sterile injectable level, not at the API-only level.
- A definitive supplier list requires fixing the exact commercial presentation (strength and container) and the sourcing route (finished product vs API).
- For supply-chain certainty, procurement should prioritize licensed finished-product manufacturers that can document the labeled “preservative free” claim per lot.
FAQs
-
Is a fentanyl citrate API supplier automatically a preservative-free injectable supplier?
No. Preservative-free status is determined by the finished drug-product formulation and labeling, not by API alone.
-
What documentation matters most for preservative-free fentanyl citrate injection purchasing?
Lot-specific CoAs, sterility and container-closure integrity documentation (finished product), and explicit verification of the labeled “preservative free” claim.
-
How do strength and container format affect supplier eligibility?
Many suppliers offer multiple concentrations or container formats. Preservative-free formulation and labeling can differ by presentation and market.
-
Can private label or hospital supply contracts change the supplier list?
Yes. A brand may be sourced from different contract manufacturers depending on lot sourcing and distribution agreements.
-
What diligence step is most important for change control?
Confirm the supplier’s manufacturing process stability and lot release criteria for the exact preservative-free presentation, including any changes in excipients or packaging components.
References
[1] U.S. Food and Drug Administration (FDA). Drug Approval Reports and labeling database (accessed via FDA resources for fentanyl citrate injection labeling and product details).
[2] European Medicines Agency (EMA). EPAR and product information resources for fentanyl citrate-containing medicinal products (accessed via EMA resources).
[3] United States Pharmacopeia (USP). General information on sterile preparations and preservative requirements applicable to injectable products (USP conventions).
